Literature DB >> 12000850

High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands.

Abdessamad Tahiri-Alaoui1, Laura Frigotto, Nick Manville, Jamal Ibrahim, Pascale Romby, William James.   

Abstract

We have isolated 2'-Fluoro-substituted RNA aptamers that bind to streptavidin (SA) with an affinity around 7 +/- 1.8 nM, comparable with that of recently described peptide aptamers. Binding to SA was not prevented by prior saturation with biotin, enabling nucleic acid aptamers to form useful ternary complexes. Mutagenesis, secondary structure analysis, ribonuclease footprinting and deletion analysis provided evidence for the essential structural features of SA-binding aptamers. In order to provide a general method for the exploitation of these aptamers, we produced derivatives in which they were fused to the naturally structured RNA elements, CopT or CopA. In parallel, we produced derivatives of CD4-binding aptamers fused to the complementary CopA or CopT elements. When mixed, these two chimeric aptamers rapidly hybridized, by virtue of CopA-CopT complementarity, to form stable, bi-functional aptamers that we called 'adaptamers'. We show that a CD4-SA-binding adaptamer can be used to capture CD4 onto a SA-derivatized surface, illustrating their general utility as indirect affinity ligands.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000850      PMCID: PMC115299          DOI: 10.1093/nar/30.10.e45

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  The use of mRNA display to select high-affinity protein-binding peptides.

Authors:  D S Wilson; A D Keefe; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins.

Authors:  C Srisawat; D R Engelke
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

3.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

4.  Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension.

Authors:  S Stern; D Moazed; H F Noller
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 5.  Probing the structure of RNAs in solution.

Authors:  C Ehresmann; F Baudin; M Mougel; P Romby; J P Ebel; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  Chemical probes for higher-order structure in RNA.

Authors:  D A Peattie; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 8.  Control of replication of bacterial plasmids: genetics, molecular biology, and physiology of the plasmid R1 system.

Authors:  K Nordström; S Molin; J Light
Journal:  Plasmid       Date:  1984-09       Impact factor: 3.466

9.  Control of replication of plasmid R1: kinetics of in vitro interaction between the antisense RNA, CopA, and its target, CopT.

Authors:  C Persson; E G Wagner; K Nordström
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

10.  Functional proteins from a random-sequence library.

Authors:  A D Keefe; J W Szostak
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

View more
  15 in total

1.  Identification and characterization of nucleobase-modified aptamers by click-SELEX.

Authors:  Franziska Pfeiffer; Fabian Tolle; Malte Rosenthal; Gerhard Markus Brändle; Jörg Ewers; Günter Mayer
Journal:  Nat Protoc       Date:  2018-04-26       Impact factor: 13.491

2.  MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation.

Authors:  Chang-Jun Li; Peng Cheng; Meng-Ke Liang; Yu-Si Chen; Qiong Lu; Jin-Yu Wang; Zhu-Ying Xia; Hou-De Zhou; Xu Cao; Hui Xie; Er-Yuan Liao; Xiang-Hang Luo
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

Review 3.  Methods for measuring aptamer-protein equilibria: a review.

Authors:  Meng Jing; Michael T Bowser
Journal:  Anal Chim Acta       Date:  2010-11-10       Impact factor: 6.558

Review 4.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

5.  Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.

Authors:  Antu K Dey; Carla Griffiths; Susan M Lea; William James
Journal:  RNA       Date:  2005-06       Impact factor: 4.942

Review 6.  Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.

Authors:  Somayeh Vandghanooni; Morteza Eskandani; Jaleh Barar; Yadollah Omidi
Journal:  J Mol Med (Berl)       Date:  2018-07-28       Impact factor: 4.599

7.  Bi-specific aptamers mediating tumor cell lysis.

Authors:  Achim Boltz; Birgit Piater; Lars Toleikis; Ralf Guenther; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

8.  Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers.

Authors:  Makobetsa Khati; Michael Schüman; Jamal Ibrahim; Quentin Sattentau; Siamon Gordon; William James
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  Chimeric aptamers in cancer cell-targeted drug delivery.

Authors:  Jagat R Kanwar; Kislay Roy; Rupinder K Kanwar
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-09-28       Impact factor: 8.250

10.  Local neutral networks help maintain inaccurately replicating ribozymes.

Authors:  András Szilágyi; Ádám Kun; Eörs Szathmáry
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.